COST AND HEALTHCARE RESOURCE UTILIZATION (HRU) RESULTING FROM IMMUNE-RELATED ADVERSE EVENTS (IRAES) AMONG PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICIS)

被引：0
|
作者：
Zheng, Y. [1 ]
Kim, R. [2 ]
Yu, T. [1 ]
Dreyfus, J. [3 ]
Gayle, J. A. [3 ]
Wassel, C. L. [3 ]
Phatak, H. [1 ]
George, S. [4 ]
机构：
[1] EMD Serono Inc, Rockland, MA USA
[2] Pfizer Inc, New York, NY USA
[3] Premier Inc, Charlotte, NC USA
[4] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN171
引用
收藏
页码：S469 / S469
页数：1
相关论文
共 50 条
  • [31] Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.
    Grizzi, Giulia
    Petrelli, Fausto
    Ghidini, Michele
    Ghidini, Antonio
    Ratti, Margherita
    Panni, Stefano
    Cabiddu, Mary
    Ghilardi, Mara
    Borgonovo, Karen
    Parati, Maria Chiara
    Barni, Sandro
    Tomasello, Gianluca
    Passalacqua, Rodolfo
    Berruti, Alfredo
    Brighenti, Matteo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Impact of obesity on the risk of immune-related adverse events (irAEs) among patients receiving immune-checkpoint inhibitors (ICI) treatment: A retrospective cohort study
    Elsaid, Mohamed I.
    Paskett, Electra D.
    Shendre, Aditi
    Manne, Ashish
    Li, Lang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Tumor- and class-specific patterns of immune-related adverse events (irAEs) of immune checkpoint inhibitors (ICIs): A systematic review (SR)
    Day, Daphne
    Khoja, Leila
    Chen, Tom Wei-Wu
    Siu, Lillian L.
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients
    Huang, Yiqing
    Aminkeng, Folefac
    Wong, Alvin S. C.
    Tay, Sen Hee
    Zhao, Joseph J.
    Ang, Yvonne
    Soo, Ross A.
    Goh, Boon Cher
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Autoimmune panels as predictors of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ALERT)
    Genta, S.
    Yee, N.
    Keshavarzi, S.
    Heirali, A.
    Hansen, A. R.
    Siu, L. L.
    Saibil, S.
    Stayner, L-A.
    Yanekina, M.
    Pimentel Muniz, T.
    Vilbert, M.
    Bedard, P.
    Abdul Razak, A. R.
    Coburn, B.
    Chruscinski, A.
    Spreafico, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S844 - S845
  • [36] Immune-related adverse events of checkpoint inhibitors
    Ramos-Casals, Manuel
    Brahmer, Julie R.
    Callahan, Margaret K.
    Flores-Chavez, Alejandro
    Keegan, Niamh
    Khamashta, Munther A.
    Lambotte, Olivier
    Marlette, Xavier
    Prat, Aleix
    Suarez-Almazor, Maria E.
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [37] Immune-related adverse events of checkpoint inhibitors
    Manuel Ramos-Casals
    Julie R. Brahmer
    Margaret K. Callahan
    Alejandra Flores-Chávez
    Niamh Keegan
    Munther A. Khamashta
    Olivier Lambotte
    Xavier Mariette
    Aleix Prat
    Maria E. Suárez-Almazor
    Nature Reviews Disease Primers, 6
  • [38] Immune-related adverse events of checkpoint inhibitors
    不详
    Nature Reviews Disease Primers, 6 (1) : 39
  • [39] Characterising immune-related adverse events in different types of cancer among Chinese patients receiving immune checkpoint inhibitors
    Zhang, Qi
    Chen, Jialing
    Tsai, Nana
    Zhu, Xuejuan
    Zhao, Minyan
    Meng, Lirong
    Fong, Pedro
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] Management of immune-related adverse events resulting from immune checkpoint blockade
    Baroudjian, Barouyr
    Arangalage, Dimitri
    Cuzzubbo, Stefania
    Hervier, Baptiste
    Lebbe, Celeste
    Lorillon, Gwenael
    Tazi, Abdellatif
    Zalcman, Gerard
    Bouattour, Mohamed
    Liote, Frederic
    Gautier, Jean-Francois
    Brosseau, Solenn
    Lourenco, Nelson
    Delyon, Julie
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (03) : 209 - 222
12345